4.2 Editorial Material

Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation

Journal

IMMUNOTHERAPY
Volume 2, Issue 3, Pages 293-297

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/IMT.10.22

Keywords

-

Categories

Funding

  1. NATIONAL CANCER INSTITUTE [R01CA109542, R01CA082222, R01CA100123] Funding Source: NIH RePORTER
  2. NCI NIH HHS [R01 CA100123, CA82222, CA109542, R01 CA109542, CA100123, R01 CA082222] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available